Phaseline

Companies › Herbarium Laboratorio Botanico Ltda

Herbarium Laboratorio Botanico Ltda: clinical trials, targets and expected readouts

2 active drug programs in 2 registered trials: 1 Phase 4, 1 Phase 1; Genitourinary, Other.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Tribulus terrestris
Botanical extract with putative effects on testosterone and spermatogenesis
–Phase 4Oligospermia–
Scar gel
Topical scar treatment
–Phase 1Acceptability Study–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06751433Scar gelPhase 1Acceptability StudyOtherDec 2025
NCT06260007Tribulus terrestrisPhase 4OligospermiaGenitourinaryFeb 2026

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Shanghai Bao Pharmaceuticals Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Shaanxi Micot Pharmaceutical Technology Sirnaomics Mylan Pharmaceuticals

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.